188 related articles for article (PubMed ID: 7537325)
1. Human papillomavirus type 16 capsids expose multiple type-restricted and type-common antigenic epitopes.
Heino P; Skyldberg B; Lehtinen M; Rantala I; Hagmar B; Kreider JW; Kirnbauer R; Dillner J
J Gen Virol; 1995 May; 76 ( Pt 5)():1141-53. PubMed ID: 7537325
[TBL] [Abstract][Full Text] [Related]
2. Antigenic and immunogenic epitopes shared by human papillomavirus type 16 and bovine, canine, and avian papillomaviruses.
Dillner L; Heino P; Moreno-Lopez J; Dillner J
J Virol; 1991 Dec; 65(12):6862-71. PubMed ID: 1719234
[TBL] [Abstract][Full Text] [Related]
3. A surface immunodeterminant of human papillomavirus type 16 minor capsid protein L2.
Kawana K; Matsumoto K; Yoshikawa H; Taketani Y; Kawana T; Yoshiike K; Kanda T
Virology; 1998 Jun; 245(2):353-9. PubMed ID: 9636375
[TBL] [Abstract][Full Text] [Related]
4. Expression in Escherichia coli of seven DNA fragments comprising the complete L1 and L2 open reading frames of human papillomavirus type 6b and localization of the 'common antigen' region.
Strike DG; Bonnez W; Rose RC; Reichman RC
J Gen Virol; 1989 Mar; 70 ( Pt 3)():543-55. PubMed ID: 2471790
[TBL] [Abstract][Full Text] [Related]
5. Mapping of linear B cell epitopes on capsid proteins of bovine papillomavirus: identification of three external type-restricted epitopes.
Cason J; Kambo PK; Jewers RJ; Chrystie IL; Best JM
J Gen Virol; 1993 Dec; 74 ( Pt 12)():2669-77. PubMed ID: 8277272
[TBL] [Abstract][Full Text] [Related]
6. Type-specific and cross-reactive epitopes in human papillomavirus type 16 capsid proteins.
Beiss BK; Heimer E; Felix A; Burk RD; Ritter DB; Mallon RG; Kadish AS
Virology; 1991 Sep; 184(1):460-4. PubMed ID: 1714667
[TBL] [Abstract][Full Text] [Related]
7. Targeting synthetic Human Papillomavirus (HPV) L2 disulfide-induced N-terminus conformational epitopes for pan-HPV vaccine development.
Khanal S; Ferraris ED; Zahin M; Joh J; Ghim SJ; Jenson AB
Exp Mol Pathol; 2015 Oct; 99(2):330-4. PubMed ID: 26134615
[TBL] [Abstract][Full Text] [Related]
8. Minor capsid protein of human genital papillomaviruses contains subdominant, cross-neutralizing epitopes.
Roden RB; Yutzy WH; Fallon R; Inglis S; Lowy DR; Schiller JT
Virology; 2000 May; 270(2):254-7. PubMed ID: 10792983
[TBL] [Abstract][Full Text] [Related]
9. Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region.
Kondo K; Ishii Y; Ochi H; Matsumoto T; Yoshikawa H; Kanda T
Virology; 2007 Feb; 358(2):266-72. PubMed ID: 17010405
[TBL] [Abstract][Full Text] [Related]
10. Immunological cross-reactivity to laboratory-produced HPV-11 virions of polysera raised against bacterially derived fusion proteins and synthetic peptides of HPV-6b and HPV-16 capsid proteins.
Christensen ND; Kreider JW; Cladel NM; Galloway DA
Virology; 1990 Mar; 175(1):1-9. PubMed ID: 2155503
[TBL] [Abstract][Full Text] [Related]
11. Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies.
Christensen ND; Dillner J; Eklund C; Carter JJ; Wipf GC; Reed CA; Cladel NM; Galloway DA
Virology; 1996 Sep; 223(1):174-84. PubMed ID: 8806551
[TBL] [Abstract][Full Text] [Related]
12. Expression of human papillomavirus type 6 and type 16 capsid proteins in bacteria and their antigenic characterization.
Banks L; Matlashewski G; Pim D; Churcher M; Roberts C; Crawford L
J Gen Virol; 1987 Dec; 68 ( Pt 12)():3081-9. PubMed ID: 2826650
[TBL] [Abstract][Full Text] [Related]
13. A two-site enzyme immunoassay for quantitation of human papillomavirus type 16 particles.
Eklund C; Dillner J
J Virol Methods; 1995 May; 53(1):11-23. PubMed ID: 7635919
[TBL] [Abstract][Full Text] [Related]
14. Reactivities of polyclonal and monoclonal antibodies raised to the major capsid protein of human papillomavirus type 16.
Patel D; Shepherd PS; Naylor JA; McCance DJ
J Gen Virol; 1989 Jan; 70 ( Pt 1)():69-77. PubMed ID: 2543739
[TBL] [Abstract][Full Text] [Related]
15. Immunological analyses of human papillomavirus capsids.
Giroglou T; Sapp M; Lane C; Fligge C; Christensen ND; Streeck RE; Rose RC
Vaccine; 2001 Feb; 19(13-14):1783-93. PubMed ID: 11166904
[TBL] [Abstract][Full Text] [Related]
16. Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV).
Huber B; Schellenbacher C; Shafti-Keramat S; Jindra C; Christensen N; Kirnbauer R
PLoS One; 2017; 12(1):e0169533. PubMed ID: 28056100
[TBL] [Abstract][Full Text] [Related]
17. Expression of the full-length products of the human papillomavirus type 6b (HPV-6b) and HPV-11 L2 open reading frames by recombinant baculovirus, and antigenic comparisons with HPV-11 whole virus particles.
Rose RC; Bonnez W; Strike DG; Reichman RC
J Gen Virol; 1990 Nov; 71 ( Pt 11)():2725-9. PubMed ID: 2174962
[TBL] [Abstract][Full Text] [Related]
18. Definition of linear antigenic regions of the HPV16 L1 capsid protein using synthetic virion-like particles.
Zhou J; Sun XY; Davies H; Crawford L; Park D; Frazer IH
Virology; 1992 Aug; 189(2):592-9. PubMed ID: 1379392
[TBL] [Abstract][Full Text] [Related]
19. Identification of immunogenic regions of the major coat protein of human papillomavirus type 16 that contain type-restricted epitopes.
Cason J; Patel D; Naylor J; Lunney D; Shepherd PS; Best JM; McCance DJ
J Gen Virol; 1989 Nov; 70 ( Pt 11)():2973-87. PubMed ID: 2479716
[TBL] [Abstract][Full Text] [Related]
20. Nasal immunization of mice with peptide having a cross-neutralization epitope on minor capsid protein L2 of human papillomavirus type 16 elicit systemic and mucosal antibodies.
Kawana K; Kawana Y; Yoshikawa H; Taketani Y; Yoshiike K; Kanda T
Vaccine; 2001 Jan; 19(11-12):1496-502. PubMed ID: 11163673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
